產(chǎn)品詳情
簡(jiǎn)單介紹：
Anti-CCDC42抗體產(chǎn)品質(zhì)量穩(wěn)定，實(shí)驗(yàn)效果明顯，貨期快，價(jià)格優(yōu)惠，歡迎垂詢訂購(gòu)！我公司長(zhǎng)期供應(yīng)**組化抗體、WB抗體、**組化試劑盒和抗體試驗(yàn)所需全部相關(guān)試劑、熒光標(biāo)記抗體、單克隆抗體、多克隆抗體、各種標(biāo)記的二抗IgG/IgM/IgD/IgA等科研實(shí)驗(yàn)抗體。Anti-CCDC42抗體用于**組化實(shí)驗(yàn),WB實(shí)驗(yàn),相應(yīng)的標(biāo)記抗體有HRP標(biāo)記抗體,FITC標(biāo)記,BIO等。
詳情介紹：
Rabbit Anti-CCDC42
Cat. Number:
Anti-CCDC42抗體KL-8131R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
The coiled-coil domain is a structural motif found in proteins that are involved in a diverse array of biological functions such as the regulation of gene expression, cell division, membrane fusion and drug extrusion and delivery. CCDC42 (coiled-coil domain containing 42) is a 316 amino acid protein encoded by a gene that Anti-CCDC42抗體maps to human chromosome 17p13.1. Encoding over 1,200 genes, chromosome 17 comprises over 2.5% of the human genome. Two key tumor suppressor genes are associated with chromosome 17, namely, p53 and BRCA1. Tumor suppressor p53 is necessary for maintenance of cellular genetic integrity by moderating cell fate through DNA repair versus cell death. Malfunction or loss of p53 expression is associated with malignant cell growth and Li-Fraumeni syndrome.
Also known as:
CCDC42A; Coiled coil domain containing 42; Coiled coil domain containing protein 42A; FLJ32734; OTTMUSP00000006142; Anti-CCDC42抗體RGD1565925; RP23-400O5.1; CCD42_HUMAN.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Dog, Pig, Cow, Horse, Rabbit, Sheep, .
●
Immunogen: KLH conjugated synthetic peptide derived from human CCDC42.
●
Predicted Molecular Weight: 38kDa.
Storage:
Shipped at 4℃, Store Anti-CCDC42抗體at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
Not yet tested in other applications.
Optimal working Anti-CCDC42抗體dilutions must be determined by the end user.
Not yet tested in other applications.
Optimal working Anti-CCDC42抗體dilutions must be determined by the end user.
kl888Ra01 補(bǔ)體成分4(C4)多克隆抗體 Polyclonal Antibody to Complement Component 4 (C4)
kl889Ca01 腎素(REN)多克隆抗體 Polyclonal Antibody to Renin (REN)
kl889Hu01 腎素(REN)多克隆抗體 Polyclonal Antibody to Renin (REN)
kl889Mu01 腎素(REN)多克隆抗體 Polyclonal Antibody to Renin (REN)
kl889Ra01 腎素(REN)多克隆抗體 Polyclonal Antibody to Renin (REN)
kl889Rb51 腎素(REN)多克隆抗體 Polyclonal Antibody to Renin (REN)
kl890Ca01 表面活性物質(zhì)關(guān)聯(lián)蛋白A(SPA)多克隆抗體 Polyclonal Antibody to Surfactant Associated Protein A (SPA)
kl890Mu01 表面活性物質(zhì)關(guān)聯(lián)蛋白A(SPA)多克隆抗體 Polyclonal Antibody to Surfactant Associated Protein A (SPA)
kl890Po01 表面活性物質(zhì)關(guān)聯(lián)蛋白A(SPA)多克隆抗體 Polyclonal Antibody to Surfactant Associated Protein A (SPA)
kl890Ra01 表面活性物質(zhì)關(guān)聯(lián)蛋白A(SPA)多克隆抗體 Polyclonal Antibody to Surfactant Associated Protein A (SPA)
kl891Hu01 花生四烯酸-15-脂加氧酶(ALOX15)多克隆抗體 Polyclonal Antibody to Arachidonate-15-Lipoxygenase (ALOX15)
kl895Hu01 胰島素受體(ISR)多克隆抗體 Polyclonal Antibody to Insulin Receptor (ISR)
kl895Ra01 胰島素受體(ISR)多克隆抗體 Polyclonal Antibody to Insulin Receptor (ISR)
kl896Po01 半胱氨酸蛋白酶抑制劑3(CST3)多克隆抗體 Polyclonal Antibody to Cystatin 3 (CST3)
kl897Hu01 血紅蛋白μ(HBμ)多克隆抗體 Polyclonal Antibody to Hemoglobin Mu (HBm)
kl899Ca01 骨橋素(OPN)多克隆抗體 Polyclonal Antibody to Osteopontin (OPN)
kl899Mu01 骨橋素(OPN)多克隆抗體 Polyclonal Antibody to Osteopontin (OPN)
kl899Po01 骨橋素(OPN)多克隆抗體 Polyclonal Antibody to Osteopontin (OPN)
kl899Ra01 骨橋素(OPN)多克隆抗體 Polyclonal Antibody to Osteopontin (OPN)
kl899Rb51 骨橋素(OPN)多克隆抗體 Polyclonal Antibody to Osteopontin (OPN)
kl901Hu01 多巴胺受體D3(DRD3)多克隆抗體 Polyclonal Antibody to Dokline Receptor D3 (DRD3)
